The effects of pre-operative angiotensinconverting enzyme inhibitor (ACEI) treatment on haemodynamic status and vasoconstrictor requirements during off-pump coronary artery bypass surgery (OPCAB) were studied. Eighty patients selected for OPCAB were divided into those who had been treated with ACEIs for 4 weeks or more pre-operatively (ACEI group) (n = 43) and those who had not been treated with ACEIs (control group) (n = 37). Noradrenaline was infused during the operation when the mean systemic arterial pressure (SAP) fell below 60 mmHg. No significant differences in the haemodynamic parameters measured were detected between the two groups, except for cardiac output, which was found to be significantly greater in the control group. During anastomosis of the obtuse marginal branch of the left circumflex artery (OM), a significantly larger amount of noradrenaline was required by the ACEI group compared with the control group. In conclusion, pre-operative treatment with ACEIs significantly increased the amount of vasoconstrictor necessary to maintain the target SAP during OM anastomosis during OPCAB. KEY WORDS: ANGIOTENSIN-CONVERTING ENZYME INHIBITOR; OFF-PUMP CORONARY ARTERY BYPASS SURGERY; HAEMODYNAMICS; NORADRENALINE YK Lee, SW Na, YL Kwak et al. Pre-operative ACEI in OPCAB surgery YK Lee, SW Na, YL Kwak et al.
Introduction
Angiotensin-converting enzyme inhibitors (ACEIs) have been used extensively in the treatment of hypertension and congestive heart failure; they dilate peripheral vessels and remodel ventricular hypertrophy by inhibiting the generation of the potent vasoconstrictor angiotensin II. 1 -3 ACEIs can increase the risk of hypotension in heart surgery patients due to their vasodilatory effects, and can also increase the need for vasoconstrictors during anaesthetic induction and after cardiopulmonary bypass (CPB). 4 There has been a rapid increase in the use of off-pump coronary artery bypass surgery (OPCAB) due to the theoretical advantages of such surgery in that it does not require CPB. 5, 6 However, the significant restriction of heart movement, as well as the occlusion of the coronary artery during anastomosis, may depress cardiac contractility and induce haemodynamic deterioration. 7, 8 To date, minimal research has been conducted with regard to the haemodynamic effects of pre-operative ACEIs in OPCAB. This study assessed the effects of pre-operative ACEIs on haemodynamic variables during surgery and on the amount of vasoconstrictor required for the maintenance of systemic arterial pressure (SAP) during coronary artery anastomosis.
Patients and methods

PATIENTS
Patients selected for OPCAB were divided according to their pre-operative medication into those who had been treated with ACEIs for 4 weeks or more pre-operatively (ACEI group) and those who had not been treated with ACEIs (control group). Patients with significant pre-operative renal or hepatic dysfunction, clinically significant ventricular ectopic activity, a left ventricular ejection fraction < 40% or single-vessel coronary artery disease, and those receiving inotropic agents, were excluded from the study.
The study protocol was approved by the Clinical Research Ethics Committee of our hospital. All patients provided informed consent before being entered into the study.
ANAESTHESIA
All normal medications were administered until the morning of the operation.
Patients were pre-medicated using an intramuscular injection of 0.05 mg/kg morphine. On arrival in the operating room, five electrocardiogram (ECG) leads were attached and leads II and V 5 were continuously monitored. A radial artery catheter was inserted in order to monitor SAP. A pulmonary artery catheter (Swan-Ganz CCOmbo-CCO/S v O 2 ® , Edwards Lifesciences LLC, Irvine, CA, USA) was inserted via the right internal jugular vein. Anaesthesia was then induced using 1.5 -2.5 mg midazolam, 1.5 -3.0 µg/kg sufentanil and 50 mg rocuronium, and the trachea was intubated. Anaesthesia was maintained by a continuous infusion of 0.5 -1.5 µg/kg per h sufentanil and 0.4 -0.6 vol% isoflurane with oxygen and air (fraction of inspired oxygen = 0.6). The ventilator was adjusted in order to ensure an arterial CO 2 tension of 30 -35 mmHg. A transoesophageal echocardiography probe was inserted after the induction of anaesthesia, and cardiac function was continuously monitored. In order to maintain normothermia, the temperature in the operating theatre was maintained at > 22°C, intravenous fluids were warmed, and a humidifier was attached to the inspiratory limb of the ventilator. Forcedair warming was applied after the veins had been harvested. Heparin at a dose of 1.0 mg/kg was administered after dissection of the internal mammary artery, and an activated clotting time of > 250 s was maintained during coronary anastomosis. A pericardial suture was placed between the left and right pulmonary veins in the posterior aspect of the pericardial reflection and a tape 2 cm wide was attached in order to elevate the apex of the heart and expose the lateral wall. To expose the individual coronary arteries, the heart was displaced using a tissue stabilizer (Octopus Tissue Stabilization System ® , Medtronic, Minneapolis, MN, USA).
All haemodynamic parameters were maintained during the operation according to internally standardized protocols. Between 1500 and 2000 ml of fluid was infused from the initiation of anaesthesia to the beginning of the coronary artery anastomosis, and then 6 -8 ml/kg per min of fluid was infused in order to maintain fluid volume at the level of the anaesthesia induction. Isosorbide dinitrate (Isoket ® , Kyung Poong Pharma Co. Ltd, Seoul, Korea) was infused at 0.05 -0.1 µg/kg per min after anaesthesia induction and throughout the operation. The operating table was tilted into a head-down position during heart displacement, and 0.03 -0.05 µg/kg per min noradrenaline was administered as required when the mean SAP decreased to < 60 mmHg. Coronary anastomosis was performed on confirmation of haemodynamic stability. A coronary artery shunt (Florester ® , Bio-Vascular Inc., St Paul, MN, USA) was inserted during the distal anastomosis of the left anterior descending artery (LAD) and the proximal portion of the right coronary artery (RCA).
If the ST segment was found to be elevated by more than 1 mV or the systolic pulmonary artery pressure increased to more than 50 mmHg before the anastomosis was performed, the heart was returned to its original position and isosorbide dinitrate was increased by 1.0 -1.5 µg/kg per min, and noradrenaline was administered in order to maintain the mean SAP. If these procedures proved unsuccessful, the patient would undergo CPB.
The same surgeon performed all the operations. The anaesthesiologists were blinded as to each patient's group.
MEASUREMENT OF HAEMODYNAMIC PARAMETERS AND NORADRENALINE USE
Haemodynamic parameters were measured at five time points: after pericardiotomy (T1); 10 min after the application of the tissue stabilizer to perform the anastomoses of the LAD, the obtuse marginal branch of the left circumflex artery (OM) and the RCA (T2, T3 and T4, respectively); and 10 min after pericardial suturing (T5). The following parameters were measured: heart rate (HR); cardiac output (CO); SAP; central venous pressure (CVP); pulmonary arterial pressure (PAP); mixed venous blood oxygen saturation (S v O 2 ); right ventricular ejection fraction (RVEF); and right ventricular end-diastolic and systolic volume indices (RVEDV and RVESV, respectively). Systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) were calculated from these data.
In addition, the amount of noradrenaline infused during the anastomoses was recorded for each patient.
STATISTICAL ANALYSIS
Comparisons between the two groups were conducted using unpaired t-tests and χ 2 tests (SPSS ® version 11.5, SPSS Inc., Chicago, IL, USA). The frequency of noradrenaline administration in the two groups was assessed using χ 2 tests. Comparisons of haemodynamic parameters between the respective groups were performed using repeated measures analysis of variance. A P-value < 0.05 was considered to be statistically significant.
Results
A total of 80 patients participated in this study. Of these, 43 had been treated with ACEIs for 4 weeks or more pre-operatively (ACEI group) and 37 had not been treated with ACEIs (control group). In the ACEI group, 26 patients had received captopril and 17 had received ramipril. The patient characteristics of the two groups are shown in Table 1 . There was a statistically significant difference between the groups with regard to gender (P < 0.05; Table 1 ). In YK Lee, SW Na, YL Kwak et al.
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addition, significantly more patients had hypertension or diabetes mellitus in the ACEI group than in the control group (Table 1) .
All 80 patients successfully underwent OPCAB; no patients required conversion to CPB.
HAEMODYNAMIC CHANGES
Analysis of systemic haemodynamic parameters revealed no significant differences between the two groups during the study period, with the exception of CO, which was significantly greater in the control group than in the ACEI group (Table 2 ). In both groups, CO and S v O 2 were significantly lower at T2 -T4 than at T1, whereas SVR was significantly higher at T2 -T4 than at T1 (P < 0.05 for both). All values, with the exception of S v O 2 , returned to baseline values at T5.
There were no significant differences in pulmonary haemodynamic parameters detected between the two groups throughout the operation (Table 3 ). In both groups, CVP and PVR were significantly higher at T2 -T4 than at T1, and RVEF was significantly lower at T2 -T4 than at T1. In the ACEI group, CVP was significantly higher at T5 than at T1, and RVEF was significantly lower at T5 than at T1 (P < 0.05 for all). No significant changes in RVEDV and RVESV were detected at any time during the operation.
NORADRENALINE REQUIREMENTS
The amounts of infused noradrenaline required during coronary anastomosis are shown in Table 4 . During OM anastomosis (T3 in Table 4 ), a significantly larger amount of noradrenaline was needed in the ACEI group than in the control group (P < 0.05). 
Discussion
The purpose of this study was to clarify the effects of pre-operative ACEI treatment on intra-operative haemodynamics and noradrenaline requirements in patients undergoing OPCAB. Greater amounts of noradrenaline were required to maintain SAP during OM anastomosis in the ACEI group than in the control group, and a significantly larger amount of noradrenaline was required by the ACEI group throughout the anastomotic procedures. There were no significant differences in the changes in haemodynamic variables, including those reflecting right ventricular function and volume. Although CO values were significantly higher in the control group at baseline and were consistently greater in the control group than in the ACEI group Values are expressed as mean ± SD. a P < 0.05 compared with T1 value in each group. T1, after pericardiotomy; T2, T3 and T4, 10 min after the application of the tissue stabilizer in order to perform anastomosis of the left anterior descending artery, the obtuse marginal branch of the left circumflex artery and the right coronary artery, respectively; T5, 10 min after pericardial suturing. CVP, central venous pressure; MPAP, mean pulmonary arterial pressure; PVR, pulmonary vascular resistance; RVEF, right ventricular ejection fraction; RVEDV, right ventricular end-diastolic volume; RVESV, right ventricular end-systolic volume.
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throughout the operation, the degree of change in CO in the groups was not significantly different. The autonomic nervous system, reninangiotensin system and vasopressin are responsible for blood pressure control in humans. In particular, the autonomic nervous system is vital to the control of SAP in conscious patients. 9 In contrast, anaesthesia inhibits the autonomic nervous system, and mechanical ventilation decreases venous return. Hypotension therefore frequently develops during and after anaesthetic induction. At this time, the activities of the renin-angiotensin system and vasopressin become important, compensating for the effect of anaesthesia and maintaining the SAP. ACEIs inhibit the conversion of angiotensin I into angiotensin II, which exerts a potent vasoconstrictive effect and results in a decrease in SAP and SVR. Hypotension during anaesthesia occurs more frequently and profoundly in patients treated with ACEIs due to this inhibition of the renin-angiotensin system. 10, 11 The degradation of bradykinin is also inhibited by ACEIs; this can increase the severity of the hypotension in patients treated with ACEIs due to the vasodilatory effects of bradykinin. 4 In addition, interaction between the adrenergic nervous system, the renin-angiotensin system and angiotensin II results in an increase in the secretion of noradrenaline, thereby reducing the re-uptake of noradrenaline in adrenergic neurons. Therefore, the level of circulating catecholamine is reduced in patients treated pre-operatively with ACEIs and the requirement for noradrenaline to maintain SAP increases. 12 Profound hypotension has been reported to occur during anaesthetic induction in patients treated with ACEIs, but can occur at any time during anaesthesia. ACEIs have also been reported to induce vasodilatory shock during CPB, and make it more difficult to wean patients from CPB in open heart surgery. 13 To date, however, there are no published studies on the effects of ACEIs in patients undergoing OPCAB, in which the use of a vasopressor is frequently required.
There are some theoretical advantages associated with OPCAB since it addresses some of the complications associated with CPB. 5, 6 OPCAB may cause unstable haemodynamic status, however, due to displacement of the heart and limited cardiac movement during exposure of the coronary arteries. 7, 8 Vertical lifting and rotation of the heart can decrease diastolic right ventricular filling by compressing the right ventricle between the pericardium and left ventricle. This effect tends to be more severe during OM anastomosis due to the involvement of the posterior heart wall. 14 -18 In the present study, the amount of noradrenaline used during OM anastomosis, as well as the total amount of noradrenaline administered during distal coronary anastomosis, was significantly greater in the ACEI group than in the control group. The increased need for noradrenaline in the ACEI group indirectly reflects an increased risk of hypotension during coronary anastomosis in these patients. As hypotension is the main cause of intraoperative myocardial ischaemia, 19 these results are relevant to the anaesthetic management of patients treated with ACEIs. There are many studies regarding the effects of ACEIs on intraoperative hypotension; however, there is little, if any, agreement as to whether ACEI treatment should be discontinued pre-operatively. 20 The present study supports the position that administering ACEIs until the morning of the surgery results in increased vasopressor requirements. Further research is needed to determine whether the YK Lee, SW Na, YL Kwak et al. Pre-operative ACEI in OPCAB surgery discontinuation of these agents would be beneficial for patients.
One of the characteristics of hypotension occurring in patients treated with ACEIs is that the response to α-adrenergic agents is attenuated. In six of the patients receiving ACEIs, the noradrenaline infusion rate was > 5 µg/kg, whereas in the control group no patients required that much noradrenaline. In one patient in the ACEI group, > 1.2 µg/kg of noradrenaline was infused during coronary anastomosis, whereas 0.43 µg/kg was the maximal infusion rate in the control group. 21 This is consistent with the results of previous studies in which the response to noradrenaline was reduced in patients treated pre-operatively with ACEIs. 10 Vasopressin has been recommended in these patients to treat hypotension, but in the present study we did not use vasopressin as there have been no studies performed regarding the effects and safety of this drug in patients undergoing OPCAB. There were no significant changes in cardiac motion on transoesophageal echocardiography or ECG during coronary anastomosis, or in SAP and CO levels after coronary anastomosis, in the six patients who received large doses of noradrenaline.
Although pre-operative ACEI medication is known to increase the frequency of intraoperative hypotension, in the present study there were no significant differences between the two groups in the number of patients requiring noradrenaline during surgery. Hypotension associated with preoperative ACEI treatment is reported to occur frequently during the induction of anaesthesia and within 30 min of induction. 22 The fact that the present study focused on time periods beginning more than 1 h after anaesthesia induction may have influenced this result. Furthermore, hypotension has been reported to develop more frequently in patients receiving ACEIs as a treatment for hypertension, 22 but no increase in the frequency or severity of hypotension was seen when ACEIs were used for heart failure treatment. 23 In our patients, ACEIs were used not only for hypertension treatment, but also for ischaemic heart disease, due principally to their afterload reduction effect as well as their inhibitory effects on the remodelling of ventricular hypertrophy. In the present study, nine patients in the ACEI group did not have hypertension, and this may have affected the results. Four of the six patients who required > 5 µg/kg of noradrenaline exhibited hypertension, but the presence of hypertension had no effect on the amount and frequency of noradrenaline use during each coronary anastomosis.
Since the patients in the ACEI group were already being treated with ACEIs when they were recruited to the study, the possibility must be borne in mind that the differences seen during OPCAB were the result of factors that led to the use of ACEIs rather than the ACEI treatment itself. Several other factors may also have influenced the development of intraoperative hypotension independent of pre-operative ACEI treatment. This problem is inherent in most studies that address the effects of ACEIs. In the present study, patients were managed according to internally standardized protocols and all the surgery was performed by one surgeon in order to minimize the surgical factors.
The fact that a larger number of patients in the ACEI group had hypertension and diabetes mellitus than in the control group constitutes another limitation of this study. If these factors are risk factors for perioperative morbidity and can induce haemodynamic instability, this difference would affect the results. There were no significant differences in the amount of noradrenaline used or the frequency of noradrenaline requirement between patients with and without hypertension or diabetes mellitus, however, both between and within the two groups.
In conclusion, pre-operative ACEI treatment increased the noradrenaline requirements during coronary anastomosis, especially during OM anastomosis, in patients undergoing OPCAB. ACEIs did not, however, exert any significant effects on intraoperative haemodynamics. Future studies should focus on the effects of pre-operative discontinuation of ACEIs.
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